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In cultured rat anterior pituitary cells, the agonist [Asu 1.6, Argqvasopressin (AVP-A) increased by 1 S-fold 
32P, incorporation into phosphatidic acid (PA), as early as 15 s after its addition. Increased phosphatidylino- 
sitol (PI) labeling became significant 4 min after AVP-A addition. Dose-response measurements with AVP- 
A showed ED,, values of 76 and 62 nM for PA and PI labeling, respectively. Peptide corticotropin-releasing 
factor (CRF) (0.1 PM) did not affect the stimulatory effect of AVP-A on PA and PI labeling. These data 
suggest that stimulation of PI metabolism in corticotrophs may be one of the early events involved in the 
stimulation of ACTH release induced by vasopressin. 
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1. INTRODUCTION 
The control of ACTH secretion is under the in- 
fluence of both stimulatory and inhibitory factors. 
Positive regulators acting directly at the anterior 
pituitary level include vasopressin [l] and the pep- 
tidic corticotropin-releasing factor (CRF) [2]. It is 
well recognized that vasopressin not only 
stimulates ACTH release when present alone but 
also potentiates the stimulatory effect of CRF on 
ACTH secretion [3]. The potentiating action of 
vasopressin is possibly mediated by the stimulatory 
effect of the neuropeptide on CRF-induced CAMP 
accumulation. 
In many endocrine cells, it has been 
demonstrated that ligand-receptor coupling trig- 
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gers the rapid increase in phosphatidylinositol (PI) 
turnover [4-61. In hepatocytes, convincing 
evidence indicates that vasopressin induces PI 
breakdown and its resynthesis through the 
phosphatidic acid (PA)-PI cycle [7-lo]. At the 
anterior pituitary level, two hypothalamic hor- 
mones, namely luteinizing hormone-releasing hor- 
mone (LHRH) and thyrotropin-releasing hormone 
(TRH) were also recently found to stimulate PA- 
PI turnover in intact [ll-131 or tumoral [14,15] 
cells in cultures. Thus we thought it of interest to 
examine the possibility that vasopressin exerts its 
early effect through changes of phospholipid 
metabolism in anterior pituitary cells. 
2. MATERIALS AND METHODS 
Anterior pituitaries obtained from adult female 
Sprague-Dawley rats at random stages of the 
estrous cycle were enzymatically dispersed and 
cultured (6 x lo5 cells/ml per dish) as previously 
described [ 131. Five days after plating, cells were 
washed 3 times with DMEM without serum before 
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a preincubation in triplicate for 20 or 30 min in 
1.5 m1 of MEM without phosphate containing 
300 &i 32Pi. Synthetic [Asu”6,Argsjvasopressin 
(AVP-A, Beckman), synthetic CRF or the vehicle 
alone (50 ~1) was then added for the indicated time 
periods or at increasing concentrations for dose- 
response studies. After incubation, the reaction 
was stopped by removing the media and cells were 
rapidly washed twice with 1 ml Hepes buffer 
before the addition of 1 ml of ice-cold 10% (w/v) 
trichloroacetic acid. Cells were then scraped from 
the dishes and the precipitated material was cen- 
trifuged at 27000 x g for 10 min. 
Polar lipids were extracted as described 
previously [ 12,131. Phospholipids were separated 
by 2-dimensional chromatography: in the first 
dimension, chloroform/methanol/28~o ammonia 
(65:35: 5, by vol.) and in the second dimension, 
chloroform/acetone/methanol/glacial cetic acid/ 
water (6:8:2:2: 1, by vol.). The different phos- 
pholipid fractions were scraped into scintillation 
vials and the radioactivity measured in a liquid 
scintillation counter. Statistical significance was 
determined by analysis of variance. Experiments 
were usually repeated 3 times. 
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Fig.1. Short time course of the effect of AVP-A on 
phosphatidic a id (PA) labeling in anterior pituitary cells 
in culture. 
3. RESULTS 
As illustrated in fig. 1, short time course ex- 
periments revealed that 0.3 FM AVP-A rapidly 
stimulates PA labeling. As early as 15 s after AVP- 
A addition to cells preincubated for 30 min with 
32Pt, incorporat’o 1 n into PA was significantly in- 
creased (7340 rt 330 vs 4510 + 140 cpm; p < 0.05). 
PI labeling was not significantly increased until 
4 min of AVP-A treatment (8440 1: 900 vs 4710 i 
350 cpm; p < 0.05). 
Longer time course experiments were then per- 
formed to analyze the duration and specificity of 
the stimulatory effect of vasopressin. As illustrated 
in fig.2, by 3 min after 0.3pM AVP-A addition, 
32Pt incorporation was increased only into PA 
(fig.2B, inset), By 9 min, however, the stimulatory 
effect was also observed in PI (1790 t 90 vs 1220 rt: 
130 cpm; p < 0.05) (fig_2A, inset) as well as in total 
phosphoIipids (34090 & 190 vs 27850 f 560 cpm; 
p < 0.01) (fig.2D, inset). In several time course ex- 
periments, this stimulatory effect of vasopressin 
was limited to PI, PA and total chloroform- 
soluble material; no significant effect of the 
neuropeptide could be detected on the labeling 
of phosphatidylserine, lysophosphatidylcholine, 
phosphatidylcholine, lysophosphatidylethanol- 
amine and phosphatidylethanolamine (fig.2C). 
Dose-response xperiments were next performed 
to assess the sensitivity of the action of AVP-A on 
PA-PI turnover (fig.3). After a 60-min incubation 
period, IOpM AVP-A led to an approx. 2-fold 
maximal enhancement of radioactivity incorpora- 
tion into PA, PI and total chIoroform-soluble 
material. EDSO values of 76 & 20, 62 + 18 and 63 
+: 11 nM were measured for PA, PI and total 
labeling, respectively. In agreement with previous 
results, PC labeling remained constant up to the 
maximal dose of AVP-A tested (10pM). 
In other experiments, we have examined the 
possibility that CRF could interact with the label- 
ing of PA-PI induced by AVP-A. Concomitant 
treatment of anterior pituitary ceils with 0.3 ,zM 
AVP-A and 0.1 /tM CRF for 20 or 60 min did not 
interfere with the stimulatory effect of AVP-A 
alone on PA-PI labeling (not shown). Also, CRF 
by itself did not induce any change in PA-PI 
labeling. 
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Fig.2 Long time course of the effect of AVP-A on phospholipid labeling in anterior pituitary cells in culture. Inset, 
enlargement of values obtained during the 3-30 min of incubation. 
4. DISCUSSION 
The present data clearly suggest hat enhanced 
PA and PI turnover might be an initial post- 
receptor event in the action of vasopressin at the 
anterior pituitary 1eveI. In fact, the rapid onset of 
the stimulatory effect of AVP-A on phospho~ipid 
labeling detected into both PA and PI and in the 
first few minutes after its addition to pituitary cells 
(fig. 1,2) represents one of the earliest biochemical 
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Fig.3. Effect of increasing concentrations of AVP-A on phospholipid labeling in anterior pituitary c&s in culture. 
responses to the hormone at the adenohypophyseal 
level reported to date. The kinetics of this effect is 
in close agrement with the speed of initial changes 
in the turnover of acidic phospholipids observed in 
many other systems [4,5]. 
The molarity for the stimulatory action of AVP- 
A at EDSO values of 76 and 62 nM for PA and PI 
labeling, respectively (fig.3), is 4- to 5-fold greater 
than the EDSO value of 14.7 nM for AVP-A- 
induced ACTH release in anterior pituitary cells in 
culture (Giguere and Labrie, unpublished data). In 
most systems where hormone effects are associated 
with enhanced PI metabolism, half-maximal 
physiologica responses occur at lower concentra- 
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metabolism and, as suggested, this effect might 
more closely parallel receptor occupancy [4,5]. 
Using an enriched population of rat pituitary 
corticotrophs [16] or mixed pituitary cells in 
culture [3], we have demonstrated that 0.1 PM syn- 
thetic CRF causes a marked stimulation of in- 
tracellular CAMP accumulation as early as 60 s 
after its addition, an effect which lasts for at least 
60 min [16]. These CAMP changes were also found 
to coincide with or precede the secretion of ACTH 
in response to CRF. Thus, the present observation 
of an increased PI turnover induced by vasopressin 
but not by CRF is consistent with a mechanism 
whereby vasopressin stimulates acidic phospho- 
lipid metabolism, probably through PI breakdown 
and its resynthesis via PA, while CRF acts in cor- 
ticotrophs primarily through elevation of CAMP. 
Stimulation of the PI cycle is a universal feature 
of hormones which exert their effects through 
elevation of intracellular Ca’+. As discussed in 
many excellent reviews of this topic [17], the 
stimulated PI cycle is probably a metabolic conse- 
quence of an initial breakdown or phosphoino- 
sitides linked in some fashion to the entry of ex- 
tracellular Ca’+ or mobilization of intracellular 
Ca’+. The current hypothesis is that agonists (such 
as vasopressin) increase triphosphoinositide (TPI) 
hydrolysis, thus liberating inositol-triphosphate, 
which in turn mobilizes intracellular Ca2+ [ 171, 
Consequently, TPI hydrolysis also seems to be the 
primary event which leads to increases in PA syn- 
thesis and PI labeling. The precise molecular 
mechanism of vasopressin action at corticotroph 
level remains to be elucidated. 
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